Correlation Between Biovaxys Technology and PsyBio Therapeutics
Can any of the company-specific risk be diversified away by investing in both Biovaxys Technology and PsyBio Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Biovaxys Technology and PsyBio Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Biovaxys Technology Corp and PsyBio Therapeutics Corp, you can compare the effects of market volatilities on Biovaxys Technology and PsyBio Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Biovaxys Technology with a short position of PsyBio Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Biovaxys Technology and PsyBio Therapeutics.
Diversification Opportunities for Biovaxys Technology and PsyBio Therapeutics
-0.02 | Correlation Coefficient |
Good diversification
The 3 months correlation between Biovaxys and PsyBio is -0.02. Overlapping area represents the amount of risk that can be diversified away by holding Biovaxys Technology Corp and PsyBio Therapeutics Corp in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on PsyBio Therapeutics Corp and Biovaxys Technology is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Biovaxys Technology Corp are associated (or correlated) with PsyBio Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of PsyBio Therapeutics Corp has no effect on the direction of Biovaxys Technology i.e., Biovaxys Technology and PsyBio Therapeutics go up and down completely randomly.
Pair Corralation between Biovaxys Technology and PsyBio Therapeutics
Assuming the 90 days horizon Biovaxys Technology Corp is expected to generate 0.22 times more return on investment than PsyBio Therapeutics. However, Biovaxys Technology Corp is 4.47 times less risky than PsyBio Therapeutics. It trades about -0.03 of its potential returns per unit of risk. PsyBio Therapeutics Corp is currently generating about -0.21 per unit of risk. If you would invest 5.33 in Biovaxys Technology Corp on September 1, 2024 and sell it today you would lose (0.30) from holding Biovaxys Technology Corp or give up 5.63% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Insignificant |
| Accuracy | 100.0% |
| Values | Daily Returns |
Biovaxys Technology Corp vs. PsyBio Therapeutics Corp
Performance |
| Timeline |
| Biovaxys Technology Corp |
| PsyBio Therapeutics Corp |
Biovaxys Technology and PsyBio Therapeutics Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Biovaxys Technology and PsyBio Therapeutics
The main advantage of trading using opposite Biovaxys Technology and PsyBio Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Biovaxys Technology position performs unexpectedly, PsyBio Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in PsyBio Therapeutics will offset losses from the drop in PsyBio Therapeutics' long position.| Biovaxys Technology vs. Rigel Pharmaceuticals | Biovaxys Technology vs. Geron | Biovaxys Technology vs. Verastem | Biovaxys Technology vs. Immutep Ltd ADR |
| PsyBio Therapeutics vs. Rigel Pharmaceuticals | PsyBio Therapeutics vs. Geron | PsyBio Therapeutics vs. Verastem | PsyBio Therapeutics vs. Immutep Ltd ADR |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Risk-Return Analysis module to view associations between returns expected from investment and the risk you assume.
Other Complementary Tools
| Analyst Advice Analyst recommendations and target price estimates broken down by several categories | |
| Money Managers Screen money managers from public funds and ETFs managed around the world | |
| Sign In To Macroaxis Sign in to explore Macroaxis' wealth optimization platform and fintech modules | |
| Portfolio Manager State of the art Portfolio Manager to monitor and improve performance of your invested capital | |
| Stock Screener Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook. |